{"id":62924,"date":"2026-04-12T04:02:22","date_gmt":"2026-04-12T02:02:22","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/rosen-law-firm-encourages-kairos-pharma-ltd-investors-to-inquire-about-securities-class-action-investigation-kapa\/"},"modified":"2026-04-12T04:02:22","modified_gmt":"2026-04-12T02:02:22","slug":"rosen-law-firm-encourages-kairos-pharma-ltd-investors-to-inquire-about-securities-class-action-investigation-kapa","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/rosen-law-firm-encourages-kairos-pharma-ltd-investors-to-inquire-about-securities-class-action-investigation-kapa\/","title":{"rendered":"Rosen Law Firm Encourages Kairos Pharma, Ltd. Investors to Inquire About Securities Class Action Investigation \u2013 KAPA"},"content":{"rendered":"
\n

NEW YORK–(BUSINESS WIRE)–Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Kairos Pharma, Ltd. (NYSE American: KAPA) resulting from allegations that Kairos Pharma may have issued materially misleading business information to the investing public.<\/p>\n

<\/a>
<\/a><\/p>\n

\nSo what: If you purchased Kairos Pharma securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.<\/p>\n

\nWhat to do next: <\/b>To join the prospective class action, go to https:\/\/rosenlegal.com\/submit-form\/?case_id=59076<\/a> or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com<\/a> for information on the class action.<\/p>\n

\nWhat is this about: Rosen Law Firm is investigating potential civil securities claims.<\/p>\n

\nWhy Rosen Law: <\/b>We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs\u2019 Bar. Many of the firm\u2019s attorneys have been recognized by Lawdragon and Super Lawyers.<\/p>\n

\nFollow us for updates on LinkedIn: https:\/\/www.linkedin.com\/company\/the-rosen-law-firm<\/a>, on Twitter: https:\/\/twitter.com\/rosen_firm<\/a> or on Facebook: https:\/\/www.facebook.com\/rosenlawfirm\/<\/a>.<\/p>\n

\nAttorney Advertising. Prior results do not guarantee a similar outcome.<\/p>\n

Contacts<\/b> <\/p>\n

\nLaurence Rosen, Esq.
\n
Phillip Kim, Esq.
\n
The Rosen Law Firm, P.A.
\n
275 Madison Avenue, 40th Floor
\n
New York, NY 10016
\n
Tel: (212) 686-1060
\n
Toll Free: (866) 767-3653
\n
Fax: (212) 202-3827
\n
case@rosenlegal.com<\/a>
<\/span>www.rosenlegal.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

NEW YORK–(BUSINESS WIRE)–Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Kairos Pharma, Ltd. (NYSE American: KAPA) resulting from allegations that Kairos Pharma may have issued materially misleading business information to the investing public. So what: If you purchased Kairos Pharma securities … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["entry","post","publish","author-business","post-62924","format-standard","category-industry"],"yoast_head":"\nRosen Law Firm Encourages Kairos Pharma, Ltd. Investors to Inquire About Securities Class Action Investigation \u2013 KAPA - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/rosen-law-firm-encourages-kairos-pharma-ltd-investors-to-inquire-about-securities-class-action-investigation-kapa\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rosen Law Firm Encourages Kairos Pharma, Ltd. Investors to Inquire About Securities Class Action Investigation \u2013 KAPA - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"NEW YORK–(BUSINESS WIRE)–Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Kairos Pharma, Ltd. (NYSE American: KAPA) resulting from allegations that Kairos Pharma may have issued materially misleading business information to the investing public. So what: If you purchased Kairos Pharma securities ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/rosen-law-firm-encourages-kairos-pharma-ltd-investors-to-inquire-about-securities-class-action-investigation-kapa\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-12T02:02:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260411226133\/en\/1164042\/22\/July_30%2C_2021_-_ROSEN_LOGO.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rosen-law-firm-encourages-kairos-pharma-ltd-investors-to-inquire-about-securities-class-action-investigation-kapa\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rosen-law-firm-encourages-kairos-pharma-ltd-investors-to-inquire-about-securities-class-action-investigation-kapa\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Rosen Law Firm Encourages Kairos Pharma, Ltd. Investors to Inquire About Securities Class Action Investigation \u2013 KAPA\",\"datePublished\":\"2026-04-12T02:02:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rosen-law-firm-encourages-kairos-pharma-ltd-investors-to-inquire-about-securities-class-action-investigation-kapa\\\/\"},\"wordCount\":397,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rosen-law-firm-encourages-kairos-pharma-ltd-investors-to-inquire-about-securities-class-action-investigation-kapa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260411226133\\\/en\\\/1164042\\\/22\\\/July_30%2C_2021_-_ROSEN_LOGO.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rosen-law-firm-encourages-kairos-pharma-ltd-investors-to-inquire-about-securities-class-action-investigation-kapa\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rosen-law-firm-encourages-kairos-pharma-ltd-investors-to-inquire-about-securities-class-action-investigation-kapa\\\/\",\"name\":\"Rosen Law Firm Encourages Kairos Pharma, Ltd. Investors to Inquire About Securities Class Action Investigation \u2013 KAPA - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rosen-law-firm-encourages-kairos-pharma-ltd-investors-to-inquire-about-securities-class-action-investigation-kapa\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rosen-law-firm-encourages-kairos-pharma-ltd-investors-to-inquire-about-securities-class-action-investigation-kapa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260411226133\\\/en\\\/1164042\\\/22\\\/July_30%2C_2021_-_ROSEN_LOGO.jpg\",\"datePublished\":\"2026-04-12T02:02:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rosen-law-firm-encourages-kairos-pharma-ltd-investors-to-inquire-about-securities-class-action-investigation-kapa\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rosen-law-firm-encourages-kairos-pharma-ltd-investors-to-inquire-about-securities-class-action-investigation-kapa\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rosen-law-firm-encourages-kairos-pharma-ltd-investors-to-inquire-about-securities-class-action-investigation-kapa\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260411226133\\\/en\\\/1164042\\\/22\\\/July_30%2C_2021_-_ROSEN_LOGO.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260411226133\\\/en\\\/1164042\\\/22\\\/July_30%2C_2021_-_ROSEN_LOGO.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rosen-law-firm-encourages-kairos-pharma-ltd-investors-to-inquire-about-securities-class-action-investigation-kapa\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rosen Law Firm Encourages Kairos Pharma, Ltd. Investors to Inquire About Securities Class Action Investigation \u2013 KAPA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rosen Law Firm Encourages Kairos Pharma, Ltd. Investors to Inquire About Securities Class Action Investigation \u2013 KAPA - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/rosen-law-firm-encourages-kairos-pharma-ltd-investors-to-inquire-about-securities-class-action-investigation-kapa\/","og_locale":"en_US","og_type":"article","og_title":"Rosen Law Firm Encourages Kairos Pharma, Ltd. Investors to Inquire About Securities Class Action Investigation \u2013 KAPA - Pharma Trend","og_description":"NEW YORK–(BUSINESS WIRE)–Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Kairos Pharma, Ltd. (NYSE American: KAPA) resulting from allegations that Kairos Pharma may have issued materially misleading business information to the investing public. So what: If you purchased Kairos Pharma securities ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/rosen-law-firm-encourages-kairos-pharma-ltd-investors-to-inquire-about-securities-class-action-investigation-kapa\/","og_site_name":"Pharma Trend","article_published_time":"2026-04-12T02:02:22+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260411226133\/en\/1164042\/22\/July_30%2C_2021_-_ROSEN_LOGO.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/rosen-law-firm-encourages-kairos-pharma-ltd-investors-to-inquire-about-securities-class-action-investigation-kapa\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/rosen-law-firm-encourages-kairos-pharma-ltd-investors-to-inquire-about-securities-class-action-investigation-kapa\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Rosen Law Firm Encourages Kairos Pharma, Ltd. Investors to Inquire About Securities Class Action Investigation \u2013 KAPA","datePublished":"2026-04-12T02:02:22+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/rosen-law-firm-encourages-kairos-pharma-ltd-investors-to-inquire-about-securities-class-action-investigation-kapa\/"},"wordCount":397,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/rosen-law-firm-encourages-kairos-pharma-ltd-investors-to-inquire-about-securities-class-action-investigation-kapa\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260411226133\/en\/1164042\/22\/July_30%2C_2021_-_ROSEN_LOGO.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/rosen-law-firm-encourages-kairos-pharma-ltd-investors-to-inquire-about-securities-class-action-investigation-kapa\/","url":"https:\/\/pharma-trend.com\/en\/rosen-law-firm-encourages-kairos-pharma-ltd-investors-to-inquire-about-securities-class-action-investigation-kapa\/","name":"Rosen Law Firm Encourages Kairos Pharma, Ltd. Investors to Inquire About Securities Class Action Investigation \u2013 KAPA - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/rosen-law-firm-encourages-kairos-pharma-ltd-investors-to-inquire-about-securities-class-action-investigation-kapa\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/rosen-law-firm-encourages-kairos-pharma-ltd-investors-to-inquire-about-securities-class-action-investigation-kapa\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260411226133\/en\/1164042\/22\/July_30%2C_2021_-_ROSEN_LOGO.jpg","datePublished":"2026-04-12T02:02:22+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/rosen-law-firm-encourages-kairos-pharma-ltd-investors-to-inquire-about-securities-class-action-investigation-kapa\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/rosen-law-firm-encourages-kairos-pharma-ltd-investors-to-inquire-about-securities-class-action-investigation-kapa\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/rosen-law-firm-encourages-kairos-pharma-ltd-investors-to-inquire-about-securities-class-action-investigation-kapa\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260411226133\/en\/1164042\/22\/July_30%2C_2021_-_ROSEN_LOGO.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260411226133\/en\/1164042\/22\/July_30%2C_2021_-_ROSEN_LOGO.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/rosen-law-firm-encourages-kairos-pharma-ltd-investors-to-inquire-about-securities-class-action-investigation-kapa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Rosen Law Firm Encourages Kairos Pharma, Ltd. Investors to Inquire About Securities Class Action Investigation \u2013 KAPA"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62924","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62924"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62924\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62924"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62924"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62924"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}